Onconova Therapeutics Inc. (ONTX) Trading Up 3.2%
Onconova Therapeutics Inc. (NASDAQ:ONTX)’s share price was up 3.2% during trading on Friday . The company traded as high as $3.69 and last traded at $3.60, with a volume of 257,658 shares traded. The stock had previously closed at $3.49.
Separately, Maxim Group began coverage on Onconova Therapeutics in a research note on Thursday. They set a “buy” rating and a $6.00 target price for the company. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $24.74.
The stock has a 50 day moving average of $4.47 and a 200-day moving average of $4.87. The firm’s market capitalization is $9.89 million.
Onconova Therapeutics (NASDAQ:ONTX) last released its earnings results on Thursday, May 12th. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by $0.08. Equities analysts expect that Onconova Therapeutics Inc. will post ($7.40) EPS for the current year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.